Stroma production within the primary tumour correlates with poor survival for stage I-II colon cancer patients

Stroma production within the primary tumour correlates with poor survival for stage I-II colon cancer patients

Show other versions (1)

Bibliographic Details
Main Authors:	Mesker, W, Johnstone, E, Van Pelt, G, Midgley, R, Liefers, G, Morreau, J, Kerr, D, Tollenaar, R
Format:	Conference item
Published:	2010

Similar Items

Stroma Production Within the Primary Tumour Correlates With Poor Survival for Stage I-II Colon Cancer Patients
by: Mesker, W, et al.
Published: (2011)

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS
by: Mesker, W, et al.
Published: (2010)

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS.
by: Mesker, W, et al.
Published: (2010)

THE INTRA-TUMOR STROMA MICROENVIRONMENT IN THERAPY MANAGEMENT FOR COLON CANCER PATIENTS
by: Mesker, W, et al.
Published: (2012)

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
by: Huijbers, A, et al.
Published: (2013)

Filling the gap between microscopic and automated analysis of the tumor-stroma ratio
by: Gabi Pelt, et al.
Published: (2020-03-01)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
by: Cor J. Ravensbergen, et al.
Published: (2021-12-01)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
by: Marloes A. Smit, et al.
Published: (2023-01-01)

High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients
by: Elizabeth Morrow, et al.
Published: (2023-06-01)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
by: Cor J. Ravensbergen, et al.
Published: (2021-10-01)

Prognosis prediction of stage II colon cancer by gene expression profiling
by: Capella, MG, et al.
Published: (2007)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
by: Midgley, R, et al.
Published: (2013)

Tumour-stroma interaction in pancreatic cancer
by: Lunardi, S
Published: (2013)

Epigenetic Mechanisms beyond Tumour–Stroma Crosstalk
by: Teresa Gagliano, et al.
Published: (2021-02-01)

The Adhesome Network: Key Components Shaping the Tumour Stroma
by: Pinelopi A. Nikolopoulou, et al.
Published: (2021-01-01)

The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
by: John Conti, et al.
Published: (2011-04-01)

Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
by: Dandan Yan, et al.
Published: (2022-10-01)

Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression
by: Seager, R J, et al.
Published: (2018)

Multicellular 3D Models to Study Tumour-Stroma Interactions
by: Elisabetta Colombo, et al.
Published: (2021-02-01)

Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma
by: Giorgio Malpeli, et al.
Published: (2024-02-01)

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?
by: Kerr, D, et al.
Published: (2010)

Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?
by: Kerr, D, et al.
Published: (2010)

Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer
by: Ewan KA Millar, et al.
Published: (2020-12-01)

Cancer of the Colon and Rectum: Treatment: Chemotherapy
by: Sabharwal, A, et al.
Published: (2009)

High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer
by: Sabine Hülsen, et al.
Published: (2020-11-01)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
by: Hannah Si Hui Lau, et al.
Published: (2023-10-01)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
by: Lau, Hannah Si Hui, et al.
Published: (2024)

Investigating prostate cancer tumour-stroma interactions - clinical and biological insights from an evolutionary game
by: Basanta, D, et al.
Published: (2012)

Crosstalk between tumour and stroma modifies CLIC4 cargo in extracellular vesicles
by: Vanesa C. Sanchez, et al.
Published: (2023-10-01)

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study
by: Tanke Hans J, et al.
Published: (2010-04-01)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
by: Midgley, R, et al.
Published: (2005)

Tissue-Engineering the Fibrous Pancreatic Tumour Stroma Capsule in 3D Tumouroids to Demonstrate Paclitaxel Response
by: Judith Pape, et al.
Published: (2021-04-01)

Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
by: Glaire, MA, et al.
Published: (2019)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
by: Midgley, R, et al.
Published: (2005)

Spatial transcriptomic interrogation of the tumour-stroma boundary in a 3D engineered model of ameloblastoma
by: Deniz Bakkalci, et al.
Published: (2024-02-01)

Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer
by: Santu Saha, et al.
Published: (2023-05-01)

Triple combination therapy for pancreatic cancer remodels stroma and improves survival
by: Karina Vázquez-Arreguín, et al.
Published: (2023-06-01)

Cancer cell survival depends on collagen uptake into tumor-associated stroma
by: Kuo-Sheng Hsu, et al.
Published: (2022-11-01)

Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing
by: Jasso, Guadalupe J, et al.
Published: (2023)

Biomarkers in early-stage colorectal cancer: ready for prime time?
by: Church, D, et al.
Published: (2012)